INSULET CORPORATION Cost of Revenue
INSULET CORPORATION (PODD) reported Cost of Revenue of $239.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- INSULET CORPORATION cost of goods and services sold for the quarter ending 2026-06-30 was $239.10M, a 21.43% increase year-over-year.
- INSULET CORPORATION cost of goods and services sold for the quarter ending 2026-03-31 was $232.70M, a 45.53% increase year-over-year.
- INSULET CORPORATION cost of goods and services sold for the quarter ending 2025-12-31 was $215.20M, a 29.17% increase year-over-year.
- INSULET CORPORATION cost of goods and services sold for the quarter ending 2025-09-30 was $196.20M, a 17.63% increase year-over-year.
- INSULET CORPORATION cost of goods and services sold for fiscal 2025 was $768.20M, a 22.74% increase from fiscal 2024.
- INSULET CORPORATION cost of goods and services sold for fiscal 2024 was $625.90M, a 16.51% increase from fiscal 2023.
- INSULET CORPORATION cost of goods and services sold for fiscal 2023 was $537.20M, a 7.50% increase from fiscal 2022.
- INSULET CORPORATION cost of goods and services sold for fiscal 2022 was $499.70M, a 44.13% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $239.10M 10-Q · filed 2026-08-05 | $471.80M 10-Q · filed 2026-08-05 | $687.00M derived: sum of 3 quarters · filed 2026-08-05 | $883.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $232.70M 10-Q · filed 2026-05-06 | $447.90M derived: sum of 2 quarters · filed 2026-05-06 | $644.10M derived: sum of 3 quarters · filed 2026-05-06 | $841.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $215.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $411.40M derived: sum of 2 quarters · filed 2026-02-18 | $608.30M derived: sum of 3 quarters · filed 2026-08-05 | $768.20M 10-K · filed 2026-02-18 | ||||
| 2025-09-30 | $196.20M 10-Q · filed 2025-11-06 | $393.10M derived: sum of 2 quarters · filed 2026-08-05 | $553.00M 10-Q · filed 2025-11-06 | $719.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $196.90M 10-Q · filed 2026-08-05 | $356.80M 10-Q · filed 2026-08-05 | $523.40M derived: sum of 3 quarters · filed 2026-08-05 | $690.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $159.90M 10-Q · filed 2026-05-06 | $160.00M 10-Q · filed 2025-05-09 | $326.50M derived: sum of 2 quarters · filed 2026-05-06 | $493.30M derived: sum of 3 quarters · filed 2026-05-06 | $650.90M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $166.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $333.40M derived: sum of 2 quarters · filed 2026-02-18 | $491.00M derived: sum of 3 quarters · filed 2026-02-18 | $625.90M 10-K · filed 2026-02-18 | ||||
| 2024-09-30 | $166.80M 10-Q · filed 2025-11-06 | $324.40M derived: sum of 2 quarters · filed 2025-11-06 | $459.30M 10-Q · filed 2025-11-06 | $607.90M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-30 | $157.60M 10-Q · filed 2025-08-07 | $292.50M 10-Q · filed 2025-08-07 | $441.10M derived: sum of 3 quarters · filed 2026-02-18 | $580.50M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-31 | $134.90M 10-Q · filed 2025-05-09 | $283.50M derived: sum of 2 quarters · filed 2026-02-18 | $422.90M derived: sum of 3 quarters · filed 2026-02-18 | $554.50M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-31 | $148.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $288.00M derived: sum of 2 quarters · filed 2026-02-18 | $419.60M derived: sum of 3 quarters · filed 2026-02-18 | $537.20M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $139.40M 10-Q · filed 2024-11-08 | $271.00M derived: sum of 2 quarters · filed 2024-11-08 | $388.60M 10-Q · filed 2024-11-08 | $541.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $131.60M 10-Q · filed 2024-08-09 | $249.20M 10-Q · filed 2024-08-09 | $401.60M derived: sum of 3 quarters · filed 2025-02-21 | $554.10M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $117.60M 10-Q · filed 2024-05-10 | $270.00M derived: sum of 2 quarters · filed 2025-02-21 | $422.50M derived: sum of 3 quarters · filed 2025-02-21 | $531.60M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $152.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $304.90M derived: sum of 2 quarters · filed 2025-02-21 | $414.00M derived: sum of 3 quarters · filed 2025-02-21 | $499.70M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $152.50M 10-Q · filed 2023-11-03 | $261.60M derived: sum of 2 quarters · filed 2023-11-03 | $347.30M 10-Q · filed 2023-11-03 | $441.80M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $109.10M 10-Q · filed 2023-08-09 | $194.80M 10-Q · filed 2023-08-09 | $289.30M derived: sum of 3 quarters · filed 2024-02-23 | $376.20M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $85.70M 10-Q · filed 2023-05-05 | $180.20M derived: sum of 2 quarters · filed 2024-02-23 | $267.10M derived: sum of 3 quarters · filed 2024-02-23 | $347.60M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $94.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $181.40M derived: sum of 2 quarters · filed 2024-02-23 | $261.90M derived: sum of 3 quarters · filed 2024-02-23 | $346.70M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $86.90M 10-Q · filed 2022-11-04 | $167.40M derived: sum of 2 quarters · filed 2022-11-04 | $252.20M 10-Q · filed 2022-11-04 | $337.20M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $80.50M 10-Q · filed 2022-08-05 | $165.30M 10-Q · filed 2022-08-05 | $250.30M derived: sum of 3 quarters · filed 2023-02-24 | $332.50M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $84.80M 10-Q · filed 2022-05-06 | $169.80M derived: sum of 2 quarters · filed 2023-02-24 | $252.00M derived: sum of 3 quarters · filed 2023-02-24 | $335.80M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $167.20M derived: sum of 2 quarters · filed 2023-02-24 | $251.00M derived: sum of 3 quarters · filed 2023-02-24 | $322.10M 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $82.20M 10-Q · filed 2021-11-05 | $166.00M derived: sum of 2 quarters · filed 2021-11-05 | $237.10M 10-Q · filed 2021-11-05 | $312.40M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $83.80M 10-Q · filed 2021-08-06 | $154.90M 10-Q · filed 2021-08-06 | $230.20M derived: sum of 3 quarters · filed 2022-02-24 | $299.20M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $71.10M 10-Q · filed 2021-05-07 | $146.40M derived: sum of 2 quarters · filed 2022-02-24 | $215.40M derived: sum of 3 quarters · filed 2022-02-24 | $276.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $75.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $144.30M derived: sum of 2 quarters · filed 2022-02-24 | $205.00M derived: sum of 3 quarters · filed 2022-02-24 | $257.90M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $69.00M 10-Q · filed 2020-11-05 | $69.03M 10-Q · filed 2019-11-06 | $129.70M derived: sum of 2 quarters · filed 2020-11-05 | $182.60M 10-Q · filed 2020-11-05 | $182.61M 10-Q · filed 2019-11-06 | $237.14M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $60.70M 10-Q · filed 2020-08-07 | $60.72M 10-Q · filed 2019-08-06 | $113.60M 10-Q · filed 2020-08-07 | $113.58M 10-Q · filed 2019-08-06 | $168.14M derived: sum of 3 quarters · filed 2021-02-24 | $217.25M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $52.90M 10-Q · filed 2020-05-08 | $52.86M 10-Q · filed 2019-05-03 | $107.44M derived: sum of 2 quarters · filed 2021-02-24 | $156.55M derived: sum of 3 quarters · filed 2021-02-24 | $198.74M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $54.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $103.65M derived: sum of 2 quarters · filed 2021-02-24 | $145.84M derived: sum of 3 quarters · filed 2021-02-24 | $193.60M 10-K · filed 2021-02-24 | $193.66M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $49.11M 10-Q · filed 2019-11-06 | $91.30M derived: sum of 2 quarters · filed 2019-11-06 | $139.06M 10-Q · filed 2019-11-06 | $190.08M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $42.19M 10-Q · filed 2019-08-06 | $89.95M 10-Q · filed 2019-08-06 | $140.97M derived: sum of 3 quarters · filed 2020-02-26 | $189.12M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $47.76M 10-Q · filed 2019-05-03 | $98.78M derived: sum of 2 quarters · filed 2020-02-26 | $146.93M derived: sum of 3 quarters · filed 2020-02-26 | $192.05M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $99.17M derived: sum of 2 quarters · filed 2020-02-26 | $144.28M derived: sum of 3 quarters · filed 2020-02-26 | $186.60M 10-K · filed 2020-02-26 | $186.60M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $48.15M 10-Q · filed 2018-11-02 | $93.27M derived: sum of 2 quarters · filed 2018-11-02 | $135.58M 10-Q · filed 2018-11-02 | $178.22M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $45.12M 10-Q · filed 2018-08-02 | $87.43M 10-Q · filed 2018-08-02 | $130.07M derived: sum of 3 quarters · filed 2019-02-26 | $169.30M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $42.31M 10-Q · filed 2018-05-04 | $84.95M derived: sum of 2 quarters · filed 2019-02-26 | $124.18M derived: sum of 3 quarters · filed 2019-02-26 | $161.06M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $42.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $81.87M derived: sum of 2 quarters · filed 2019-02-26 | $118.74M derived: sum of 3 quarters · filed 2019-02-26 | $155.90M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $39.23M 10-Q · filed 2017-11-03 | $76.10M derived: sum of 2 quarters · filed 2017-11-03 | $113.27M 10-Q · filed 2017-11-03 | $155.07M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $36.87M 10-Q · filed 2017-08-04 | $74.03M 10-Q · filed 2017-08-04 | $115.84M derived: sum of 3 quarters · filed 2018-02-22 | $155.67M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $37.16M 10-Q · filed 2017-05-09 | $78.97M derived: sum of 2 quarters · filed 2018-02-22 | $118.79M derived: sum of 3 quarters · filed 2018-02-22 | $148.83M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $41.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $81.63M derived: sum of 2 quarters · filed 2018-02-22 | $111.67M derived: sum of 3 quarters · filed 2018-02-22 | $130.62M 10-K · filed 2018-02-22 | $176.07M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $39.82M 10-Q · filed 2016-11-04 | $51.65M 10-Q · filed 2015-11-06 | $69.86M derived: sum of 2 quarters · filed 2016-11-04 | $88.81M 10-Q · filed 2016-11-04 | $121.27M 10-Q · filed 2015-11-06 | $83.47M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $30.04M 10-Q · filed 2016-08-04 | $41.21M 10-Q · filed 2015-08-12 | $48.99M 10-Q · filed 2016-08-04 | $69.62M 10-Q · filed 2015-08-12 | $43.64M derived: sum of 3 quarters · filed 2017-02-28 | $80.58M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $18.95M 10-Q · filed 2016-04-29 | $28.41M 10-Q · filed 2015-04-30 | $13.61M derived: sum of 2 quarters · filed 2017-02-28 | $50.55M derived: sum of 3 quarters · filed 2017-02-28 | $86.80M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $31.59M derived: sum of 2 quarters · filed 2017-02-28 | $67.84M derived: sum of 3 quarters · filed 2017-02-28 | $104.19M 10-K · filed 2017-02-28 | $145.43M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $36.94M 10-Q · filed 2015-11-06 | $73.19M derived: sum of 2 quarters · filed 2015-11-06 | $109.54M 10-Q · filed 2015-11-06 | $105.74M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-06-30 | $36.25M 10-Q · filed 2015-08-12 | $72.60M 10-Q · filed 2015-08-12 | $68.80M derived: sum of 3 quarters · filed 2016-09-06 | $102.50M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-03-31 | $36.35M 10-Q · filed 2015-04-30 | $32.55M derived: sum of 2 quarters · filed 2016-09-06 | $66.26M derived: sum of 3 quarters · filed 2016-09-06 | $99.52M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2013-12-31 | -$3.80M derived: 8-K 12 month − 10-Q 9 month · filed 2016-09-06 | $29.90M derived: sum of 2 quarters · filed 2016-09-06 | $63.16M derived: sum of 3 quarters · filed 2016-09-06 | $95.36M 8-K · filed 2016-09-06 | $134.68M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $33.71M 10-Q · filed 2014-11-05 | $66.97M derived: sum of 2 quarters · filed 2014-11-05 | $99.17M 10-Q · filed 2014-11-05 | $131.68M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $33.26M 10-Q · filed 2014-08-07 | $65.46M 10-Q · filed 2014-08-07 | $97.97M derived: sum of 3 quarters · filed 2015-02-26 | $128.33M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $32.20M 10-Q · filed 2014-05-07 | $64.71M derived: sum of 2 quarters · filed 2015-02-26 | $95.07M derived: sum of 3 quarters · filed 2015-02-26 | $123.78M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $32.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $62.87M derived: sum of 2 quarters · filed 2015-02-26 | $91.58M derived: sum of 3 quarters · filed 2015-02-26 | $119.03M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $30.36M 10-Q · filed 2013-11-07 | $59.07M derived: sum of 2 quarters · filed 2013-11-07 | $86.52M 10-Q · filed 2013-11-07 | $113.64M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $28.70M 10-Q · filed 2013-08-08 | $56.16M 10-Q · filed 2013-08-08 | $83.27M derived: sum of 3 quarters · filed 2014-02-28 | $109.31M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $27.46M 10-Q · filed 2013-05-08 | $54.57M derived: sum of 2 quarters · filed 2014-02-28 | $80.60M derived: sum of 3 quarters · filed 2014-02-28 | $98.28M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $27.11M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-28 | $53.15M derived: sum of 2 quarters · filed 2014-02-28 | $70.82M derived: sum of 3 quarters · filed 2014-02-28 | $85.54M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $26.03M 10-Q/A · filed 2013-02-28 | $43.71M derived: sum of 2 quarters · filed 2013-02-28 | $58.43M 10-Q/A · filed 2013-02-28 | $72.37M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $17.67M 10-Q/A · filed 2013-02-28 | $32.40M 10-Q/A · filed 2013-02-28 | $46.34M derived: sum of 3 quarters · filed 2013-02-28 | $60.16M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $14.72M 10-Q/A · filed 2013-02-28 | $28.67M derived: sum of 2 quarters · filed 2013-02-28 | $42.49M derived: sum of 3 quarters · filed 2013-02-28 | $55.54M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $13.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-02-28 | $27.77M derived: sum of 2 quarters · filed 2013-02-28 | $40.82M derived: sum of 3 quarters · filed 2013-02-28 | $53.24M 10-K/A · filed 2013-02-28 | ||||
| 2010-09-30 | $13.83M 10-Q · filed 2011-11-08 | $26.88M derived: sum of 2 quarters · filed 2011-11-08 | $39.30M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $13.05M 10-Q · filed 2011-08-09 | $25.47M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $47.73M 10-K/A · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |